Quarterly report · Q2
3939.TEDINET S100TDG1
Period2023-10-01 → 2024-03-31
Filed2024-05-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.4bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥3.7bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.7bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥669m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥559m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥675m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥565m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥684m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥588m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥458m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥763m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥406m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥458m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥406m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥5.6bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥5.7bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥6.5bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.2bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥2.5bn | at 2023-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥3.4bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.2bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.8bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.7bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.9bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.6bn | at 2022-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥438m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.4bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥339m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥194m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥842m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥242m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥434m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.3bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥405m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥9.65 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.27 | 2024-01-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.08 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.55 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.06 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥15.58 | 2022-10-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥8.09 | 2022-10-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 60.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.2% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 32
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥5m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥5m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥21m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥613m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥613m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥15m |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥1.6bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥1.6bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥1m |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥641m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥285m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥281m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥4m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥34m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-03-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-03-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥5m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-03-31 | ¥690m |
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2023-03-31 | −¥52,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2023-03-31 | −¥52,000 |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥3m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥384m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥384m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥10m |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥1.4bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥1.4bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥52,000 |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥553m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-10-01 → 2023-03-31 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-10-01 → 2023-03-31 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥52,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-10-01 → 2023-03-31 | ¥563m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 539
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)高野 浩一郎 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)川口 靖仁 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 1736970000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 2446366000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 3746460000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 565174000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 675282000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1107012000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 405727000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 458071000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 763100000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 404561000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 460651000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 763238000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 2816272000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 3374504000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 3174949000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 6508371000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 5606868000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 5653058000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 8.55 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 9.65 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 16.08 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 8.09 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 15.58 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.433 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.602 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.562 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 338642000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 438481000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1430090000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -242036000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -194314000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -842249000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -404954000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -433673000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -2267283000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 4242366000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 2685522000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 2872526000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 5.06 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 5.27 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 48132000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 48132000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 48132000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 48132000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |